INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Other Current Assets
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Other Current Assets of $203.96 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for the quarter ending 2026-06-30 was $187.84K, a 22.23% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for the quarter ending 2026-03-31 was $362.96K, a 232.42% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for the quarter ending 2025-12-31 was -$8.05K, a 110.05% decline year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$338.79K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for fiscal 2026 was $203.96K, a 38.08% decline from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for fiscal 2025 was $329.40K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for fiscal 2024 was -$55.22K, a 146.66% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in other current assets for fiscal 2023 was $118.33K, a 64.54% decline from fiscal 2022.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 3 month as first filed | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 6 month as first filed | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $187.84K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $550.80K derived: sum of 2 quarters · filed 2026-08-19 | $542.75K derived: sum of 3 quarters · filed 2026-08-19 | $203.96K 10-K · filed 2026-08-19 | ||
| 2026-03-31 | $362.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $354.91K derived: sum of 2 quarters · filed 2026-05-13 | $16.11K 10-Q · filed 2026-05-13 | $257.63K derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-12-31 | -$8.05K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$346.84K 10-Q · filed 2026-02-12 | -$105.32K derived: sum of 3 quarters · filed 2026-08-19 | $3.86K derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-09-30 | -$338.79K 10-Q · filed 2025-11-12 | -$97.27K derived: sum of 2 quarters · filed 2026-08-19 | $11.91K derived: sum of 3 quarters · filed 2026-08-19 | $91.99K derived: sum of 4 quarters · filed 2026-08-19 | ||
| 2025-06-30 | $241.52K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $350.71K derived: sum of 2 quarters · filed 2026-08-19 | $430.78K derived: sum of 3 quarters · filed 2026-08-19 | $329.40K 10-K · filed 2026-08-19 | ||
| 2025-03-31 | $109.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $189.26K derived: sum of 2 quarters · filed 2026-05-13 | $87.88K 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $80.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$21.30K 10-Q · filed 2026-02-12 | -$148.89K 10-Q · filed 2025-02-13 | |||
| 2024-09-30 | -$101.38K 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | -$55.22K 10-K · filed 2025-08-15 | |||||
| 2023-12-31 | -$81.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | -$221.19K 10-Q · filed 2025-02-13 | -$290.13K derived: sum of 3 quarters · filed 2025-02-13 | -$15.81K derived: sum of 4 quarters · filed 2025-02-13 | ||
| 2023-09-30 | -$139.49K 10-Q · filed 2024-11-07 | -$208.42K derived: sum of 2 quarters · filed 2024-11-07 | $65.89K derived: sum of 3 quarters · filed 2024-11-07 | -$228.25K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | -$68.94K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $205.38K derived: sum of 2 quarters · filed 2024-09-18 | -$88.77K derived: sum of 3 quarters · filed 2024-09-18 | $118.33K 10-K · filed 2024-09-18 | ||
| 2023-03-31 | $274.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | -$19.83K derived: sum of 2 quarters · filed 2024-05-08 | $187.27K 10-Q · filed 2024-05-08 | $667.87K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | -$294.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-09 | -$87.04K 10-Q · filed 2024-02-09 | $393.55K derived: sum of 3 quarters · filed 2024-02-09 | $511.56K derived: sum of 4 quarters · filed 2024-02-09 | ||
| 2022-09-30 | $207.10K 10-Q · filed 2023-11-08 | -$92.90K 10-Q · filed 2022-11-14 | $687.70K derived: sum of 2 quarters · filed 2023-11-08 | $805.71K derived: sum of 3 quarters · filed 2023-11-08 | $781.09K derived: sum of 4 quarters · filed 2023-11-08 | |
| 2022-06-30 | $480.60K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $598.60K derived: sum of 2 quarters · filed 2023-08-23 | $573.99K derived: sum of 3 quarters · filed 2023-08-23 | $333.74K 10-K · filed 2023-08-23 | ||
| 2022-03-31 | $118.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-11 | $93.39K derived: sum of 2 quarters · filed 2023-05-11 | -$146.85K 10-Q · filed 2023-05-11 | $37.77K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$24.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-14 | -$264.86K 10-Q · filed 2023-02-14 | -$80.23K derived: sum of 3 quarters · filed 2023-02-14 | $2.16M derived: sum of 4 quarters · filed 2023-02-14 | ||
| 2021-09-30 | -$240.25K 10-Q · filed 2022-11-14 | -$55.62K derived: sum of 2 quarters · filed 2022-11-14 | $2.18M derived: sum of 3 quarters · filed 2022-11-14 | $2.22M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $184.63K derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $2.42M derived: sum of 2 quarters · filed 2022-09-22 | $2.46M derived: sum of 3 quarters · filed 2022-09-22 | $2.46M 10-K · filed 2022-09-22 | ||
| 2021-03-31 | $2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-05-16 | $2.28M derived: sum of 2 quarters · filed 2022-05-16 | $2.28M 10-Q · filed 2022-05-16 | $2.27M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $40.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-02-11 | $39.49K 10-Q · filed 2022-02-11 | $34.48K derived: sum of 3 quarters · filed 2022-02-11 | $13.15K derived: sum of 4 quarters · filed 2022-02-11 | ||
| 2020-09-30 | -$705.00 10-Q · filed 2021-11-12 | -$5.71K derived: sum of 2 quarters · filed 2021-11-12 | -$27.05K derived: sum of 3 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | -$26.34K derived: sum of 2 quarters · filed 2021-09-16 | -$99.28K 10-K · filed 2021-09-16 | |||
| 2020-03-31 | -$21.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | -$94.27K 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | -$72.94K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |